Correlation Between GlaxoSmithKline PLC and 1st Source

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and 1st Source at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and 1st Source into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and 1st Source, you can compare the effects of market volatilities on GlaxoSmithKline PLC and 1st Source and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of 1st Source. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and 1st Source.

Diversification Opportunities for GlaxoSmithKline PLC and 1st Source

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and 1st is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and 1st Source in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 1st Source and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with 1st Source. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 1st Source has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and 1st Source go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and 1st Source

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 4.26 times less return on investment than 1st Source. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.44 times less risky than 1st Source. It trades about 0.01 of its potential returns per unit of risk. 1st Source is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  5,179  in 1st Source on August 26, 2024 and sell it today you would earn a total of  1,450  from holding 1st Source or generate 28.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  1st Source

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
1st Source 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in 1st Source are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, 1st Source may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and 1st Source Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and 1st Source

The main advantage of trading using opposite GlaxoSmithKline PLC and 1st Source positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, 1st Source can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 1st Source will offset losses from the drop in 1st Source's long position.
The idea behind GlaxoSmithKline PLC ADR and 1st Source pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device